Added to YB: 2025-06-03
Pitch date: 2025-06-01
NEULANDLAB.NS [neutral]
Neuland Laboratories Limited
+40.79%
current return
Author Info
Momentum Financial researches stocks from around the world to invest in for the long-term. Sign up for the newsletter.
Company Info
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
Market Cap
INR 147.6B
Pitch Price
INR 11.4K
Price Target
N/A
Dividend
0.10%
EV/EBITDA
45.00
P/E
56.73
EV/Sales
9.85
Sector
Pharmaceuticals
Category
turnaround
Investing in India. - Neuland Laboratories Limited
NEULANDLAB.NS (quick overview): API manufacturer down 19% YTD on 4.7% revenue/13.4% profit decline from product lifecycle changes. Business 'inherently irregular' due to CDMO/specialty GDS focus - 3yr view better. Unit 3 at 30-40% utilization, peptide expansion ongoing. Europe/US generate 86% of revenue. PE 56 (range 15-81), +2,849% 5yr on improved financials.
Read full article (2 min)